Watchlist Manager

Watchlist

Price: 8 250 KRW 1.23% Market Closed

Market Cap: ₩131.8B

	Jeil Pharma Holdings Inc KRX:002620	KR

Income Statement

Currency: KRW

	Dec-2005	Mar-2006	Jun-2006	Sep-2006	Dec-2006	Mar-2007	Jun-2007	Sep-2007	Dec-2007	Mar-2008	Jun-2008	Sep-2008	Dec-2008	Mar-2009	Jun-2009	Sep-2009	Dec-2009	Mar-2010	Jun-2010	Sep-2010	Dec-2010	Mar-2011	Jun-2011	Sep-2011	Dec-2011	Mar-2012	Jun-2012	Sep-2012	Dec-2012	Mar-2013	Jun-2013	Sep-2013	Dec-2013	Mar-2014	Jun-2014	Sep-2014	Dec-2014	Mar-2015	Jun-2015	Sep-2015	Dec-2015	Mar-2016	Jun-2016	Sep-2016	Dec-2016	Mar-2017	Jun-2017	Sep-2017	Dec-2017	Mar-2018	Jun-2018	Sep-2018	Dec-2018	Mar-2019	Jun-2019	Sep-2019	Dec-2019	Mar-2020	Jun-2020	Sep-2020	Dec-2020	Mar-2021	Jun-2021	Sep-2021	Dec-2021	Mar-2022	Jun-2022	Sep-2022	Dec-2022	Mar-2023	Jun-2023	Sep-2023	Dec-2023	Mar-2024	Jun-2024	Sep-2024	Dec-2024	Mar-2025	Jun-2025	Sep-2025
Revenue
Interest Expense	880	943	1 010	1 009	948	933	798	690	635	523	527	573	615	692	736	714	621	0	0	0	0	0	0	0	320	0	0	0	753	0	0	0	754	0	183	333	659	597	536	556	573	455	343	189	48	38	27	17	19	20	29	384	1 017	1 807	2 478	2 752	2 858	2 922	3 080	3 197	3 194	3 022	2 802	2 681	3 289	3 721	4 326	5 320	5 952	7 379	8 933	10 085	10 672	10 833	10 327	9 524	8 875	8 090	7 790	7 640
Revenue	248 609 N/A	251 456 +1%	255 834 +2%	257 636 +1%	267 132 +4%	277 770 +4%	287 817 +4%	291 247 +1%	305 441 +5%	311 430 +2%	315 005 +1%	319 602 +1%	319 440 0%	323 936 +1%	337 777 +4%	354 929 +5%	369 487 +4%	386 077 +4%	402 480 +4%	415 135 +3%	431 307 +4%	441 004 +2%	441 024 +0%	458 682 +4%	462 853 +1%	461 677 0%	462 787 +0%	442 166 -4%	426 819 -3%	423 599 -1%	425 865 +1%	432 975 +2%	451 968 +4%	466 078 +3%	483 457 +4%	501 589 +4%	512 736 +2%	537 213 +5%	551 528 +3%	571 066 +4%	594 716 +4%	461 633 -22%	323 628 -30%	181 365 -44%	40 604 -78%	40 823 +1%	41 355 +1%	43 658 +6%	48 236 +10%	53 134 +10%	59 708 +12%	64 031 +7%	142 736 +123%	306 883 +115%	475 938 +55%	641 559 +35%	731 805 +14%	741 802 +1%	749 593 +1%	757 246 +1%	761 997 +1%	759 246 0%	759 041 0%	767 983 +1%	762 568 -1%	771 045 +1%	791 598 +3%	788 177 0%	792 965 +1%	805 169 +2%	791 025 -2%	790 514 0%	804 043 +2%	785 871 -2%	783 556 0%	778 787 -1%	779 822 +0%	773 034 -1%	735 787 -5%	707 153 -4%
Gross Profit
Cost of Revenue	(169 256)	(175 386)	(177 055)	(175 874)	(181 289)	(187 285)	(195 131)	(199 014)	(208 135)	(214 074)	(219 349)	(222 761)	(224 114)	(223 564)	(229 471)	(238 339)	(247 980)	(261 941)	(273 593)	(283 467)	(297 059)	(299 536)	(308 676)	(322 580)	(329 680)	(338 145)	(339 182)	(329 971)	(319 039)	(317 222)	(318 490)	(326 680)	(342 552)	(353 536)	(364 992)	(380 121)	(383 861)	(405 424)	(419 324)	(433 759)	(454 500)	(350 875)	(244 335)	(133 116)	(24 887)	(24 089)	(23 635)	(23 874)	(23 133)	(23 638)	(25 090)	(25 472)	(86 279)	(217 748)	(349 773)	(477 384)	(549 304)	(552 978)	(559 323)	(568 197)	(570 757)	(570 591)	(570 204)	(579 527)	(582 061)	(590 813)	(610 891)	(609 200)	(612 482)	(607 669)	(591 618)	(588 640)	(589 459)	(583 470)	(577 282)	(575 674)	(573 301)	(556 901)	(511 979)	(459 110)
Gross Profit	79 353 N/A	76 072 -4%	78 781 +4%	81 764 +4%	85 844 +5%	90 485 +5%	92 686 +2%	92 233 0%	97 306 +6%	97 356 +0%	95 656 -2%	96 841 +1%	95 326 -2%	100 373 +5%	108 307 +8%	116 591 +8%	121 507 +4%	124 135 +2%	128 886 +4%	131 667 +2%	134 248 +2%	141 468 +5%	132 348 -6%	136 102 +3%	133 173 -2%	123 532 -7%	123 605 +0%	112 194 -9%	107 781 -4%	106 376 -1%	107 374 +1%	106 295 -1%	109 417 +3%	112 541 +3%	118 464 +5%	121 466 +3%	128 875 +6%	131 790 +2%	132 206 +0%	137 310 +4%	140 215 +2%	110 760 -21%	79 295 -28%	48 251 -39%	15 717 -67%	16 736 +6%	17 720 +6%	19 783 +12%	25 103 +27%	29 494 +17%	34 618 +17%	38 560 +11%	56 457 +46%	89 137 +58%	126 166 +42%	164 176 +30%	182 501 +11%	188 824 +3%	190 269 +1%	189 048 -1%	191 239 +1%	188 654 -1%	188 837 +0%	188 457 0%	180 507 -4%	180 232 0%	180 707 +0%	178 978 -1%	180 483 +1%	197 500 +9%	199 407 +1%	201 874 +1%	214 584 +6%	202 402 -6%	206 274 +2%	203 113 -2%	206 521 +2%	216 133 +5%	223 808 +4%	248 044 +11%
Operating Income
Operating Expenses	(64 398)	(65 788)	(69 105)	(73 800)	(73 870)	(76 726)	(77 900)	(77 331)	(79 101)	(79 957)	(79 246)	(80 442)	(79 649)	(80 088)	(81 263)	(82 626)	(82 572)	(84 067)	(82 480)	(85 521)	(92 150)	(95 559)	(98 135)	(97 866)	(102 317)	(101 926)	(103 689)	(107 178)	(101 460)	(107 873)	(111 427)	(110 447)	(108 043)	(112 000)	(114 022)	(115 901)	(120 324)	(122 792)	(123 479)	(127 601)	(127 067)	(98 151)	(70 005)	(40 213)	(12 584)	(13 117)	(14 389)	(15 456)	(20 736)	(24 335)	(28 581)	(32 197)	(45 508)	(75 886)	(108 069)	(143 726)	(172 970)	(175 087)	(175 832)	(176 414)	(168 759)	(174 346)	(181 450)	(183 168)	(189 482)	(207 455)	(210 952)	(208 911)	(188 031)	(261 762)	(262 480)	(263 844)	(193 764)	(228 383)	(245 548)	(246 149)	(218 080)	(266 029)	(254 342)	(212 007)
Selling, General & Administrative	(57 103)	(58 789)	(61 990)	(65 875)	(67 330)	(69 182)	(70 819)	(70 848)	(73 059)	(73 974)	(73 388)	(74 745)	(73 690)	(72 766)	(73 427)	(73 619)	(73 991)	(79 132)	(80 473)	(86 680)	(94 870)	(98 071)	(100 046)	(100 144)	(84 726)	(96 426)	(97 545)	(100 177)	(83 198)	(96 134)	(99 688)	(98 708)	(89 958)	(107 677)	(105 184)	(101 807)	(102 702)	(104 243)	(104 585)	(108 212)	(105 857)	(81 927)	(58 676)	(34 388)	(10 614)	(11 372)	(12 637)	(13 639)	(19 922)	(23 562)	(27 334)	(30 996)	(40 832)	(65 744)	(93 833)	(124 518)	(149 600)	(152 455)	(152 250)	(150 599)	(142 445)	(144 836)	(148 931)	(147 140)	(149 808)	(149 831)	(148 398)	(150 588)	(146 465)	(146 684)	(146 001)	(145 188)	(147 727)	(150 159)	(170 799)	(172 559)	(179 129)	(183 223)	(169 424)	(172 153)
Research & Development	(5 906)	(5 694)	(5 943)	(7 085)	(5 740)	(6 799)	(6 310)	(5 737)	(5 317)	(5 241)	(5 123)	(4 957)	(5 213)	(6 589)	(7 128)	(8 318)	(8 372)	0	0	0	0	0	0	0	(17 591)	(5 194)	0	0	(18 263)	(4 722)	0	0	(18 086)	(4 323)	(8 619)	(13 578)	(16 767)	(17 829)	(18 248)	(18 727)	(20 299)	(15 538)	(10 870)	(5 596)	(1 554)	(1 328)	(1 334)	(1 400)	(701)	(659)	(1 134)	(1 088)	(4 512)	(9 977)	(14 071)	(18 776)	(22 452)	(22 037)	(22 987)	(25 095)	(24 731)	(28 882)	(31 719)	(37 458)	(39 673)	(42 744)	(45 699)	(41 468)	(41 566)	(36 743)	(38 144)	(40 321)	(46 038)	(49 621)	(46 145)	(44 986)	(38 950)	(37 601)	(39 714)	(39 854)
Depreciation & Amortization	(1 389)	(1 305)	(1 173)	(842)	(800)	(745)	(771)	(745)	(726)	(742)	(736)	(740)	(747)	(734)	(708)	(690)	(209)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(220)	(435)	(856)	0	(647)	(662)	(911)	0	0	0	(415)	0	0	0	(112)	0	0	0	(165)	0	0	(434)	(919)	0	0	(721)	(1 583)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0
Other Operating Expenses	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(4 935)	(2 007)	1 159	2 719	2 513	1 912	2 279	0	(306)	(6 144)	(7 001)	0	(7 017)	(11 739)	(11 739)	0	0	0	(81)	0	(720)	0	0	0	(686)	(459)	(229)	0	(417)	(418)	(417)	0	(114)	(113)	(113)	0	(165)	(165)	0	0	(595)	(595)	0	0	(628)	(800)	1 430	0	(14 880)	(16 856)	(16 856)	0	(78 335)	(78 335)	(78 335)	0	(28 604)	(28 604)	(28 604)	0	(45 204)	(45 204)	0
Operating Income	14 955 N/A	10 284 -31%	9 675 -6%	7 962 -18%	11 973 +50%	13 757 +15%	14 784 +7%	14 901 +1%	18 204 +22%	17 399 -4%	16 410 -6%	16 400 0%	15 676 -4%	20 285 +29%	27 044 +33%	33 964 +26%	38 935 +15%	40 069 +3%	46 407 +16%	46 148 -1%	42 098 -9%	45 910 +9%	34 214 -25%	38 237 +12%	30 856 -19%	21 608 -30%	19 917 -8%	5 016 -75%	6 321 +26%	(1 499) N/A	(4 054) -170%	(4 153) -2%	1 373 N/A	541 -61%	4 442 +721%	5 566 +25%	8 551 +54%	8 998 +5%	8 726 -3%	9 708 +11%	13 148 +35%	12 608 -4%	9 289 -26%	8 036 -13%	3 133 -61%	3 617 +15%	3 331 -8%	4 327 +30%	4 368 +1%	5 161 +18%	6 037 +17%	6 363 +5%	10 949 +72%	13 249 +21%	18 096 +37%	20 448 +13%	9 531 -53%	13 736 +44%	14 437 +5%	12 634 -12%	22 481 +78%	14 308 -36%	7 385 -48%	5 288 -28%	(8 975) N/A	(27 223) -203%	(30 244) -11%	(29 934) +1%	(7 548) +75%	(64 262) -751%	(63 073) +2%	(61 970) +2%	20 820 N/A	(25 982) N/A	(39 274) -51%	(43 036) -10%	(11 559) +73%	(49 896) -332%	(30 534) +39%	36 036 N/A
Pre-Tax Income
Interest Income Expense	6 832	8 072	8 251	8 218	9 273	9 278	9 309	10 495	8 443	8 840	9 871	10 607	10 189	9 961	8 402	7 354	4 723	2 503	467	(489)	4 375	5 667	7 376	8 419	4 765	3 992	3 384	4 310	4 323	1 381	(12)	(1 921)	424	(31)	575	1 154	1 643	1 562	2 092	2 108	1 257	2 325	2 149	1 643	2 704	1 167	1 023	573	1 101	1 449	2 571	2 141	396	(25)	(1 594)	(1 434)	5 673	5 878	4 976	4 078	7 843	9 710	11 633	12 461	14 393	11 776	11 513	11 068	2 588	3 715	3 253	1 649	(4 936)	(6 410)	(15 082)	(15 655)	(5 258)	(5 436)	(728)	1 859
Non-Reccuring Items	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(131)	0	0	0	(1 170)	0	(82)	0	(82)	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 727)	(1 727)	(1 938)	(1 938)	(97 744)	(97 272)	(97 089)	(96 751)	644	0	2 176	0	(14 880)	0	0	0	(78 335)	0	0	0	(28 604)	0	0	0	(45 204)	0	0	(44 396)
Gain/Loss on Disposition of Assets	4	23	33	33	37	29	0	17	14	11	0	0	8	0	6	7	7	0	0	0	0	0	0	0	13	0	0	0	(168)	0	0	0	58	0	0	0	39	66	76	0	38	0	0	(11)	(2)	0	0	0	0	0	0	0	0	3	3	3	3	0	1	8	8	8	37	0	31	39	9	20	35	38	42	31	6	0	3	3	14	19	12	21
Total Other Income	(840)	(1 111)	(1 065)	(1 478)	(1 380)	(1 276)	(1 510)	(851)	(1 543)	63	2 580	1 734	813	575	(1 163)	(1 030)	308	337	(168)	(83)	0	0	0	0	1 676	4 063	4 416	7 856	3 283	10 517	10 433	7 182	1 413	311	434	339	1 683	1 319	1 419	1 708	1 607	1 501	717	409	6	(264)	33	58	36	45	75	91	170	158	222	567	325	361	(31)	(375)	(155)	19	742	3 202	3 302	3 116	2 716	(394)	(600)	(734)	(620)	(619)	(1 268)	(1 101)	(1 263)	(323)	381	221	523	377
Pre-Tax Income	20 951 N/A	17 268 -18%	16 895 -2%	14 736 -13%	19 903 +35%	21 788 +9%	22 583 +4%	24 560 +9%	25 118 +2%	26 312 +5%	28 861 +10%	28 741 0%	26 687 -7%	30 821 +15%	34 289 +11%	40 296 +18%	43 973 +9%	42 909 -2%	46 706 +9%	45 576 -2%	46 473 +2%	51 577 +11%	41 591 -19%	46 658 +12%	37 311 -20%	29 664 -20%	27 717 -7%	17 182 -38%	13 628 -21%	10 399 -24%	6 367 -39%	1 107 -83%	2 098 +90%	820 -61%	5 369 +555%	7 060 +31%	11 834 +68%	11 946 +1%	12 312 +3%	13 524 +10%	16 050 +19%	16 434 +2%	12 156 -26%	10 078 -17%	5 842 -42%	4 520 -23%	4 386 -3%	4 958 +13%	5 504 +11%	6 656 +21%	8 684 +30%	8 596 -1%	9 788 +14%	11 657 +19%	14 788 +27%	17 645 +19%	(82 213) N/A	(77 297) +6%	(77 706) -1%	(80 406) -3%	30 822 N/A	24 045 -22%	21 974 -9%	20 951 -5%	(6 129) N/A	(12 293) -101%	(16 007) -30%	(19 240) -20%	(83 861) -336%	(61 242) +27%	(60 398) +1%	(60 910) -1%	(13 982) +77%	(33 492) -140%	(55 617) -66%	(59 011) -6%	(61 626) -4%	(55 091) +11%	(30 726) +44%	(6 102) +80%
Net Income
Tax Provision	(8 615)	(7 651)	(9 865)	(9 716)	(9 076)	(10 985)	(10 080)	(10 109)	(11 444)	(11 866)	(11 176)	(11 214)	(9 152)	(9 901)	(12 296)	(14 257)	(15 975)	(15 402)	(22 185)	(21 275)	(20 282)	(21 204)	(11 271)	(12 413)	(10 296)	(8 301)	(7 643)	(4 664)	(2 456)	(1 276)	(42)	1 455	(1 614)	(1 800)	(3 670)	(5 651)	(9 739)	(9 720)	(9 788)	(9 849)	(6 288)	(6 146)	(4 800)	(2 873)	(2 082)	(1 130)	(1 364)	(1 523)	57	(884)	(1 231)	(1 126)	(2 486)	(4 038)	(5 476)	(7 344)	(13 296)	(13 720)	(12 771)	(11 258)	(15 881)	(14 521)	(14 617)	(14 860)	(6 741)	(6 186)	(5 007)	(4 975)	716	957	701	1 181	741	409	(4 235)	(3 690)	(4 765)	(4 928)	192	(4 526)
Income from Continuing Operations	12 336	9 616	7 028	5 018	10 827	10 802	12 502	14 451	13 674	14 445	17 684	17 525	17 535	20 919	21 993	26 039	27 998	27 507	24 520	24 300	26 190	30 372	30 320	34 245	27 015	21 363	20 074	12 519	11 172	9 125	6 327	2 563	484	(980)	1 699	1 409	2 095	2 226	2 524	3 674	9 761	10 288	7 356	7 206	3 760	3 391	3 023	3 437	5 561	5 773	7 453	7 469	7 302	7 618	9 312	10 301	(95 509)	(91 016)	(90 476)	(91 662)	14 941	9 525	7 358	6 090	(12 870)	(18 479)	(21 013)	(24 215)	(83 145)	(60 285)	(59 697)	(59 728)	(13 241)	(33 084)	(59 852)	(62 701)	(66 391)	(60 019)	(30 534)	(10 627)
Income to Minority Interest	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	0	(1 582)	(1 891)	(2 076)	(105 976)	(525)	(301)	(222)	103 531	(232)	(305)	(1 367)	(1 956)	5 017	3 060	2 988	3 650	(3 510)	(1 356)	(216)	474	9 388	11 907	13 043	14 842	8 589	(2 240)	(2 193)	(2 026)	(3 009)	7 067	20 317	21 225	15 232	11 112	(4 652)	(18 785)
Net Income (Common)	12 336 N/A	9 616 -22%	7 028 -27%	5 018 -29%	10 827 +116%	10 802 0%	12 502 +16%	14 451 +16%	13 674 -5%	14 445 +6%	17 684 +22%	17 525 -1%	17 535 +0%	20 919 +19%	21 993 +5%	26 039 +18%	27 998 +8%	27 507 -2%	24 520 -11%	24 300 -1%	26 190 +8%	30 372 +16%	30 320 0%	34 245 +13%	27 015 -21%	21 363 -21%	20 074 -6%	12 519 -38%	11 172 -11%	9 125 -18%	6 327 -31%	2 563 -59%	484 -81%	(980) N/A	1 699 N/A	1 409 -17%	2 095 +49%	2 226 +6%	2 524 +13%	3 674 +46%	9 761 +166%	10 570 +8%	9 402 -11%	8 538 -9%	6 308 -26%	5 098 -19%	520 542 +10 111%	417 769 -20%	520 351 +25%	521 037 +0%	5 035 -99%	108 805 +2 061%	7 070 -94%	7 313 +3%	7 946 +9%	8 346 +5%	(90 492) N/A	(87 956) +3%	(87 489) +1%	(88 013) -1%	11 431 N/A	8 169 -29%	7 142 -13%	6 564 -8%	(3 482) N/A	(6 572) -89%	(7 970) -21%	(9 373) -18%	(74 556) -695%	(62 525) +16%	(61 890) +1%	(61 754) +0%	(16 250) +74%	(26 016) -60%	(39 535) -52%	(41 476) -5%	(51 159) -23%	(48 907) +4%	(35 186) +28%	(29 412) +16%
EPS (Diluted)	3 084 N/A	2 404 -22%	1 757 -27%	1 254.5 -29%	2 706.75 +116%	2 700.5 0%	3 125.5 +16%	3 612.75 +16%	3 418.5 -5%	3 611.25 +6%	4 421 +22%	4 381.25 -1%	4 383.75 +0%	5 229.75 +19%	5 498.25 +5%	6 509.75 +18%	6 999.5 +8%	6 876.75 -2%	6 130 -11%	6 075 -1%	6 547.5 +8%	7 593 +16%	7 580 0%	8 561.25 +13%	6 753.75 -21%	5 340.75 -21%	5 018.5 -6%	3 129.75 -38%	2 793 -11%	2 281.25 -18%	1 581.75 -31%	640.75 -59%	121 -81%	-245 N/A	424.75 N/A	352.25 -17%	523.75 +49%	556.5 +6%	631 +13%	918.5 +46%	2 440.25 +166%	1 321.25 -46%	1 969.28 +49%	2 134.5 +8%	1 577 -26%	1 699.33 +8%	130 135.5 +7 558%	104 442.25 -20%	130 087.75 +25%	130 259.25 +0%	1 258.75 -99%	27 201.25 +2 061%	1 414 -95%	487.53 -66%	529.73 +9%	556.4 +5%	-6 032.8 N/A	-5 863.73 +3%	-5 832.6 +1%	-5 867.53 -1%	762.06 N/A	544.6 -29%	465.2 -15%	427.59 -8%	-226.85 N/A	-428.09 -89%	-519.21 -21%	-610.61 -18%	-4 856.7 -695%	-4 073.01 +16%	-4 031.62 +1%	-4 022.79 +0%	-1 058.54 +74%	-1 694.76 -60%	-2 575.39 -52%	-2 701.85 -5%	-3 332.61 -23%	-3 185.87 +4%	-2 292.1 +28%	-1 915.97 +16%

Income Statement Balance Sheet Cash Flow Statement

Jeil Pharma Holdings Inc
KRX:002620

Income Statement

Earnings Waterfall
Jeil Pharma Holdings Inc

Income Statement
Jeil Pharma Holdings Inc

See Also

Company

Help

Tools

Stocks

Jeil Pharma Holdings Inc KRX:002620

Income Statement

Earnings Waterfall Jeil Pharma Holdings Inc

Income Statement Jeil Pharma Holdings Inc

See Also

Company

Help

Tools

Stocks

Jeil Pharma Holdings Inc
KRX:002620

Earnings Waterfall
Jeil Pharma Holdings Inc

Income Statement
Jeil Pharma Holdings Inc